Kerecis Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Employees
-
505
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$1.16B
Kerecis General Information
Description
Manufacturer of fish skin-based therapeutic products intended to speed up the healing of human wounds and repair tissue damage. The company's therapeutic products contain Omega-3 fatty acids extracted from fish skin to reconstruct tissue damage such as burn and diabetic wounds as well as for oral wounds, hernia repair, and breast reconstruction, enabling medical practitioners to treat patients' wounds, burns, and other dermatological conditions effectively.
Contact Information
Website
www.kerecis.com(Operating Subsidiary)
Corporate Office
- Sundstraeti 38
- P.O. Box 151
- Isafjordur, 400
- Iceland
Corporate Office
- Sundstraeti 38
- P.O. Box 151
- Isafjordur, 400
- Iceland
Kerecis Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Merger/Acquisition | 31-Aug-2023 | $1.16B | Completed | Generating Revenue | ||
| 12. Later Stage VC (Series D) | 21-Jul-2022 | Completed | Generating Revenue | |||
| 11. Later Stage VC | 01-Jul-2020 | Completed | Generating Revenue | |||
| 10. Later Stage VC (Series C) | 13-Jun-2019 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series B2) | 23-May-2018 | Completed | Generating Revenue | |||
| 8. Grant | 21-Oct-2016 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series B1) | 01-Oct-2015 | Completed | Generating Revenue | |||
| 6. Secondary Transaction - Private | 01-Jan-2014 | Completed | Startup | |||
| 5. Early Stage VC (Series A3) | 01-Dec-2013 | $1.9M | $7.44M | Completed | Startup | |
| 4. Early Stage VC (Series A2) | 26-Apr-2013 | $1.7M | $5.54M | Completed | Startup |
Kerecis Comparisons
Industry
Financing
Details
Kerecis Competitors (17)
One of Kerecis’s 17 competitors is Noveome Biotherapeutics, a Venture Capital-Backed company based in Pittsburgh, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Noveome Biotherapeutics | Venture Capital-Backed | Pittsburgh, PA | ||||
| TheraSource | Corporation | Manhasset, NY | ||||
| Rakuten Medical | Venture Capital-Backed | San Diego, CA | ||||
| EpiBone | Venture Capital-Backed | New York, NY | ||||
| IFM Therapeutics | Venture Capital-Backed | Boston, MA |
Kerecis Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Kerecis Patents
Kerecis Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025069002-A1 | Wound dressing | Inactive | 29-Sep-2023 | ||
| WO-2025069003-A1 | Wound treatment devices, kits, systems, and methods | Inactive | 29-Sep-2023 | ||
| WO-2024057291-A1 | Systems for making a fat-inclusive skin graft treatment composition, fat-inclusive skin graft treatment composition, and methods of making same | Inactive | 16-Sep-2022 | ||
| JP-2025510091-A | Systems, devices and methods for recognizing defects in medical implant treatments - patents.com | Active | 25-Mar-2022 | ||
| WO-2023181014-A1 | Systems, devices, and methods for recognizing defects in medical graft processing | Inactive | 25-Mar-2022 | G06V10/82 |
Kerecis Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Kerecis Former Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 1924 | Venture Capital | Minority | ||
| Brú lífeyrissjóður starfsmanna sveitarfélaga | Limited Partner | Minority | ||
| Capital ehf | Venture Capital | Minority | ||
| EHF Capital | Family Office | Minority | ||
| Emerson Collective | Impact Investing | Minority |
Kerecis Acquisitions (1)
Kerecis’s most recent deal was a Merger/Acquisition with Phytoceuticals. The deal was made on 07-Feb-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Phytoceuticals | 07-Feb-2019 | Merger/Acquisition | Biotechnology |
Kerecis FAQs
-
When was Kerecis founded?
Kerecis was founded in 2007.
-
Where is Kerecis headquartered?
Kerecis is headquartered in Isafjordur, Iceland.
-
What is the size of Kerecis?
Kerecis has 505 total employees.
-
What industry is Kerecis in?
Kerecis’s primary industry is Drug Discovery.
-
Is Kerecis a private or public company?
Kerecis is a Private company.
-
What is the current valuation of Kerecis?
The current valuation of Kerecis is .
-
What is Kerecis’s current revenue?
The current revenue for Kerecis is .
-
How much funding has Kerecis raised over time?
Kerecis has raised $150M.
-
Who are Kerecis’s investors?
1924, Brú lífeyrissjóður starfsmanna sveitarfélaga, Capital ehf, EHF Capital, and Emerson Collective are 5 of 15 investors who have invested in Kerecis.
-
Who are Kerecis’s competitors?
Noveome Biotherapeutics, TheraSource, Rakuten Medical, EpiBone, and IFM Therapeutics are some of the 17 competitors of Kerecis.
-
When was Kerecis acquired?
Kerecis was acquired on 31-Aug-2023.
-
Who acquired Kerecis?
Kerecis was acquired by Coloplast.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
